Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
21 hedge funds and large institutions have $6.3M invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 21 → 21 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
38% less capital invested
Capital invested by funds: $10.2M → $6.3M (-$3.88M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$23.4K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$5.35K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$68.9K |
| 2 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$39K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.94K |
| 4 |
FIG
Fortress Investment Group
New York
|
-$1.35K |
CTV.WS Hedge Fund Activity: Q1 2023 in Review
21 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q1 2023, worth a combined $6.3M — down 38% from $10.2M a quarter earlier.
Fund positioning in CTV.WS was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Menora Mivtachim Holdings, opening a new position worth an estimated $23.4K. The largest seller was BAMCO Inc, cutting an estimated $68.9K.
- 21 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $6.3M of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q1 2023, down 38% quarter-over-quarter.
- 3 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q1 2023 and 3 closed out, a net change of 0 holders.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q1 2023 was Menora Mivtachim Holdings, an estimated $23.4K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q1 2023 was BAMCO Inc, an estimated $68.9K sold.
Based on aggregated 13F filings for Q1 2023.